Short-Chain Fatty Acid Levels after Fecal Microbiota Transplantation in a Pediatric Cohort with Recurrent <i>Clostridioides difficile</i> Infection

Though antibiotics are the mainstay treatment for <i>Clostridioides difficile</i>, a large population of individuals infected will experience recurrence. In turn, fecal microbiota transplantation (FMT) has emerged as a promising treatment for recurrent <i>C. difficile</i> inf...

Full description

Bibliographic Details
Published in:	Metabolites
Main Authors:	Alison T. Jess, George Hany Eskander, My H. Vu, Sonia Michail
Format:	Article
Language:	English
Published:	MDPI AG 2023-09-01
Subjects:	<i>C. difficile</i> SCFA pediatric FMT propionate isovalerate
Online Access:	https://www.mdpi.com/2218-1989/13/10/1039

Similar Items

The Regulatory Approach for Faecal Microbiota Transplantation as Treatment for <i>Clostridioides difficile</i> Infection in Italy
by: Maria Chiara de Stefano, et al.
Published: (2022-04-01)

Impact of Fecal Microbiota Transplant Formulations, Storage Conditions, and Duration on Bacterial Viability, Functionality, and Clinical Outcomes in Patients with Recurrent <i>Clostridioides difficile</i> Infection
by: Mohamed Shaheen, et al.
Published: (2025-03-01)

The Efficacy of Fecal Microbiota Transplantation in Mouse Models Infected with <i>Clostridioides difficile</i> from the Perspective of Metabolic Profiling: A Systematic Review
by: Anna Voziki, et al.
Published: (2024-12-01)

Ten-Year Follow-Up of Patients Treated with Fecal Microbiota Transplantation for Recurrent <i>Clostridioides difficile</i> Infection from a Randomized Controlled Trial and Review of the Literature
by: R. E. Ooijevaar, et al.
Published: (2021-03-01)

The Efficacy of Faecal Microbiota Transplant and Rectal Bacteriotherapy in Patients with Recurrent <i>Clostridioides difficile</i> Infection: A Retrospective Cohort Study
by: Camilla Kara Svensson, et al.
Published: (2022-10-01)

Metabolic Phenotyping Study of Mouse Brain Following Microbiome Disruption by <i>C. difficile</i> Colonization
by: Olga Deda, et al.
Published: (2022-10-01)

Fecal Metabolomics for the Diagnosis of <i>Clostridioides difficile</i> Infection
by: Carlos Bea-Serrano, et al.
Published: (2025-09-01)

Identification of Simplified Microbial Communities That Inhibit Clostridioides difficile Infection through Dilution/Extinction
by: Jennifer M. Auchtung, et al.
Published: (2020-08-01)

Extraintestinal Manifestations of <i>Clostridioides difficile</i> Infections: An Overview
by: Konstantinos Mpakogiannis, et al.
Published: (2025-07-01)

Development of a Protocol for Anaerobic Preparation and Banking of Fecal Microbiota Transplantation Material: Evaluation of Bacterial Richness in the Cultivated Fraction
by: Berta Bosch, et al.
Published: (2023-12-01)

Microbiota in <i>Clostridioides difficile</i>-Associated Diarrhea: Comparison in Recurrent and Non-Recurrent Infections
by: Alessandra Gazzola, et al.
Published: (2020-09-01)

Updated Management Guidelines for <i>Clostridioides difficile</i> in Paediatrics
by: Margherita Gnocchi, et al.
Published: (2020-04-01)

Diversity, Dynamics and Therapeutic Application of <i>Clostridioides difficile</i> Bacteriophages
by: Janet Y. Nale, et al.
Published: (2022-12-01)

Investigation of Intestinal Microbiota and Fecal Calprotectin in Non-Toxigenic and Toxigenic <i>Clostridioides difficile</i> Colonization and Infection
by: Sung-Hee Han, et al.
Published: (2020-06-01)

High Prevalence of <i>Clostridioides difficile</i> Ribotype 176 in the University Hospital in Kosice
by: Katarina Curova, et al.
Published: (2023-03-01)

Fecal microbiota transplantation via colonoscopy in a dog with Clostridioides (Clostridium) difficile infection
by: Amanda Nadia Diniz, et al.
Published: (2021-02-01)

Prevalence of Non-Toxigenic <i>Clostridioides difficile</i> in Diarrhoea Patients and Their Clinical Characteristics
by: Cheon-Hoo Jeon, et al.
Published: (2023-08-01)

Nasogastric Delivery of Fecal Microbiota Transplantation for the Treatment of Fulminant Clostridioides difficile Infection: A Case Report
by: Amitjeet Singh, et al.
Published: (2025-05-01)

Application of Microbiome Management in Therapy for <i>Clostridioides difficile</i> Infections: From Fecal Microbiota Transplantation to Probiotics to Microbiota-Preserving Antimicrobial Agents
by: Chun-Wei Chiu, et al.
Published: (2021-05-01)

Occurrence of <i>Blastocystis</i> in Patients with <i>Clostridioides difficile</i> Infection
by: Laura Vega, et al.
Published: (2020-04-01)

A Review of Therapies for <i>Clostridioides difficile</i> Infection
by: Faiza Morado, et al.
Published: (2024-12-01)

Gut Microbiota Composition Associated with <i>Clostridioides difficile</i> Colonization and Infection
by: Elisa Martinez, et al.
Published: (2022-07-01)

Early Life Antimicrobial Exposure: Impact on <i>Clostridioides difficile</i> Colonization in Infants
by: Chinwe Vivien Obiakor, et al.
Published: (2022-07-01)

<i>Clostridioides difficile</i>, a New “Superbug”
by: Rumyana Markovska, et al.
Published: (2023-03-01)

Fecal Microbiota Transplantation for Recurrent <i>Clostridioides difficile</i> Infections in a Cystic Fibrosis Child Previously Screen Positive, Inconclusive Diagnosis (CFSPID): A Case Report
by: Riccardo Marsiglia, et al.
Published: (2024-10-01)

Prevalence of <i>Clostridioides difficile</i> Infection in Critically Ill Patients with Extreme Leukocytosis and Diarrhea
by: Bijan Teja, et al.
Published: (2021-01-01)

Co-Colonization of Non-<i>difficile</i> Clostridial Species in Antibiotic-Associated Diarrhea Caused by <i>Clostridioides difficile</i>
by: Daniel Salas-Treviño, et al.
Published: (2025-04-01)

Teicoplanin Suppresses Vegetative <i>Clostridioides difficile</i> and Spore Outgrowth
by: Suvash Chandra Ojha, et al.
Published: (2021-08-01)

An Update on <i>Clostridioides difficile</i> Binary Toxin
by: Adrián Martínez-Meléndez, et al.
Published: (2022-04-01)

Clostridioides difficile infection: microbe-microbe interactions and live biotherapeutics
by: Ruojun Wang
Published: (2023-05-01)

Encapsulation protocol for fecal microbiota transplantation
by: Dávid Sipos, et al.
Published: (2024-06-01)

Antimicrobial Effects of Some Natural Products on Adhesion and Biofilm Inhibition of <i>Clostridioides difficile</i>
by: Dorota Wultańska, et al.
Published: (2024-03-01)

Opportunities for Nanomedicine in <i>Clostridioides difficile</i> Infection
by: Pei-Wen Wang, et al.
Published: (2021-08-01)

Assessing the Feasibility of Employing a Combination of a Bacteriophage-Derived Endolysin and Spore Germinants to Treat Relapsing <i>Clostridioides difficile</i> Infection
by: Khalid Alyahya, et al.
Published: (2023-06-01)

Baicalein and Berberine Inhibit the Growth and Virulence of <i>Clostridioides difficile</i>
by: Xue Yang, et al.
Published: (2025-07-01)

<i>Clostridioides difficile</i> Infection: Diagnosis and Treatment Challenges
by: John E. Markantonis, et al.
Published: (2024-01-01)

Review of the Impact of Biofilm Formation on Recurrent <i>Clostridioides difficile</i> Infection
by: Daira Rubio-Mendoza, et al.
Published: (2023-10-01)

Effect of Pefloxacin on <i>Clostridioides difficile</i> R20291 Persister Cells Formation
by: Camila Queraltó, et al.
Published: (2025-06-01)

Effect of Restriction of Fluoroquinolone Antibiotics on <i>Clostridioides difficile</i> Infections in the University Hospital Hradec Králové
by: Kristýna Vaverková, et al.
Published: (2021-05-01)

Mobilome of Environmental Isolates of <i>Clostridioides difficile</i>
by: Khald Blau, et al.
Published: (2025-07-01)